Median incomes have not kept pace with the inflation rate for job-based health insurance costs, straining family budgets. » Read More
The deaths had come in the company's "ROCKET" trial for patients with relapsed or refractory B cell acute lymphoblastic leukemia.
Shares of Shire rose more than 3 percent after it won approval from the FDA for its new dry-eye treatment Xiidra.
SAGE skyrockets after it announces results for a trial involving a drug to treat postpartum depression.
Obama wrote that a 'public option' would give Obamacare customers more choice.
JPMorgan analysts slashed the target price of Humana from $196 to $150 after reports the DOJ may block the acquisition by Aetna.
Juno plunged more than 31 percent, a day after the FDA halted a study on a potential cancer treatment following two patients deaths.
Shkreli sought "advice for a new and wealthy player" on a Reddit thread about the game Magic.
Shares of Humana dived more than 10 percent after speculation from analysts that the DOJ wants to meet over antitrust concerns.
Obamacare plans often have comparable premiums and deductibles to employer-based coverage for lower-income customers.
Congress must agree on a bill to fund efforts to control the Zika virus next week, or risk harm to pregnant women and their babies.
Shares of BioMarin jumped more than 10 percent in early trading after a report said Roche may be seeking to acquire it.
Poor people now have lower overall health spending than other income groups, reversing a longtime pattern.
Fewer smokers quit when tobacco surcharges were lower for Obamacare plans, a new study shows.
Pfizer will disclose that painkillers can carry serious risk of addiction and promised not to promote opiates for unapproved uses.
Shares of Chemours and Dow component DuPont fell sharply after DuPont was found liable for a man's testicular cancer.
Doctors now authorized to write buprenorphine prescriptions to 100 patients can go up to 275 patients under new rules.
Get the best of CNBC in your inbox